ÂÜÀòÂÒÂ×

Elizabeth J Ackermann PhD has extensive work experience in the field of clinical development and scientific research. Elizabeth J currently holds the position of Senior Vice President of Clinical Development at Avidity Biosciences, Inc. since October 2021. Prior to this, they served as the Vice President of Clinical Development at Avidity Biosciences, Inc. from January 2020 to October 2021.

Before joining Avidity Biosciences, Inc., Dr. Ackermann held the position of Vice President of Clinical Development at Otonomy, Inc. from March 2019 to December 2019. Elizabeth J also served as the Chief Science Officer at the Myotonic Dystrophy Foundation from March 2018 to September 2018.

Dr. Ackermann gained valuable experience at Ionis Pharmaceuticals, Inc. where they held various positions including Vice President of Clinical Development from September 2017 to February 2018, Executive Director of Clinical Development from June 2014 to September 2017, Director of Clinical Development from January 2012 to June 2014, and Associate Director of Clinical Development from August 2009 to January 2012.

Elizabeth J'searlier career includes roles such as Clinical Project Manager at Synteract, Inc. from December 2007 to August 2009, Principle Scientist and Project Team Leader at TorreyPines Therapeutics from August 2000 to December 2007, Scientist at Mitokor from February 1999 to July 2000, and Postdoctoral Fellow at Ionis Pharmaceuticals, Inc. from 1997 to 1999.

Dr. Ackermann began their career as an NIH Postdoctoral Fellow at the UCSD Pharmacology Dept: Palmer Taylor from 1995 to 1997.

Elizabeth J Ackermann earned a Ph.D. in Biochemistry from UC San Diego.